The Latest on the Intracept Procedure

We have the data showing the Intracept Procedure works, but the real proof can be found in the innovations, updates, and engagements our team brings to the CLBP world every day. Each is an example of a company on the move—and on a mission.

Sr. Digital Marketing Manager

Relievant Medsystems, Inc.: We provide life-changing relief to patients by transforming the diagnosis and treatment of chronic lower back pain. Our culture enables employees to thrive by practicing our core values of Integrity, Passion, Respect, Collaboration,...

Relievant Medsystems Announces Publication of New INTRACEPT Trial Data Demonstrating Long-Term Relief for Chronic Low Back Pain 24 Months Post-Procedure

Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced 24-month results from a Level 1, prospective, randomized, multi-center trial (INTRACEPT) that further validate the safety, effectiveness, and durability of the Intracept® Procedure for patients with vertebrogenic CLBP.

Relievant Medsystems Announces New Vertebrogenic Low Back Pain ICD-10 Diagnosis Code

Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain (CLBP), today announced the Centers for Disease Control and Prevention (CDC) has designated an International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) diagnosis code specifically for vertebrogenic low back pain.